Recombinant anti-TNFα antibody (Sailemin Biotech)

重组人TNFα单抗（赛乐敏生物）

Report date: 2022/01/14 13:23:58

Base Information

Drug NameRecombinant anti-TNFα antibody (Sailemin Biotech)
Drug Alias NameN/A
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody
Mechanisms of ActionTumor necrosis factor α inhibitors
TargetsTumor necrosis factor α
Therapy Area/IndicationsArthritis, RheumatoidSpondylitis, Ankylosing
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusDiscontinued (IND)
Highest Status in ChinaDiscontinued
Originator CompaniesZhong Anti-Bio Pharmaceutical (Haikou) Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesSinomab Bioscience (Shenzhen) LtdZhong Anti-Bio Pharmaceutical (Haikou) Co Ltd
Active IndicationsN/A
Inactive IndicationsArthritis, RheumatoidSpondylitis, Ankylosing

Other Information

ATC CodeN/A
Related LinksN/A